Clinical application of Octacalcium phosphate(OCP) in the spine surgery

Clinical application of Octacalcium phosphate of spinal interbody fusion surgery: A prospective, open-label, case control study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0011295

Enrollment

Registered

2025-12-10

Start date

2024-05-27

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : In spinal fusion surgery, bone graft materials are used to promote fusion. In the intervention group, Octacalcium Phosphate (OCP) is additionally inserted along with the bone graft ma

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing interbody fusion surgery at the Department of Orthopedic Surgery, Seoul Metropolitan Boramae Hospital, due to spinal disorders, who consent to the use of the specified material.

Exclusion criteria

Exclusion criteria: Patients who refuse the use of materials related to the clinical trial. Pregnant women.

Design outcomes

Primary

Measure	Time frame
Occurrence of complications including Infection, Inflammation / Paralysis, Neurological injury / Bleeding, Hematoma	—

Secondary

Measure	Time frame
Fusion rate	—

Countries

Korea, Republic of

Contacts

Public ContactTae Hoon Kang

Seoul Metropolitan Government Seoul National University Boramae Medical Center

kangth1503@naver.com+82-2-870-2271

Outcome results